Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum

Mai Yoshikawa, Kazunori Motoshima, Kanji Fujimoto, Akihiro Tai, Hiroki Kakuta, Kenji Sasaki

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains.

Original languageEnglish
Pages (from-to)6027-6033
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number11
DOIs
Publication statusPublished - Jun 1 2008

Fingerprint

Schizonts
Chloroquine
Antimalarials
Plasmodium falciparum
Dimers
Plasmodium
Cytotoxicity
Developing countries
Developing Countries
Malaria
Cause of Death

Keywords

  • Antimalarials
  • Cationic-dimer
  • Hammett's σ
  • Hansch-Fujita π
  • Synchronized culture

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum. / Yoshikawa, Mai; Motoshima, Kazunori; Fujimoto, Kanji; Tai, Akihiro; Kakuta, Hiroki; Sasaki, Kenji.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 11, 01.06.2008, p. 6027-6033.

Research output: Contribution to journalArticle

@article{2cb384a5de804512874add0c286c1f4b,
title = "Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum",
abstract = "Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains.",
keywords = "Antimalarials, Cationic-dimer, Hammett's σ, Hansch-Fujita π, Synchronized culture",
author = "Mai Yoshikawa and Kazunori Motoshima and Kanji Fujimoto and Akihiro Tai and Hiroki Kakuta and Kenji Sasaki",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.bmc.2008.04.051",
language = "English",
volume = "16",
pages = "6027--6033",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum

AU - Yoshikawa, Mai

AU - Motoshima, Kazunori

AU - Fujimoto, Kanji

AU - Tai, Akihiro

AU - Kakuta, Hiroki

AU - Sasaki, Kenji

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains.

AB - Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains.

KW - Antimalarials

KW - Cationic-dimer

KW - Hammett's σ

KW - Hansch-Fujita π

KW - Synchronized culture

UR - http://www.scopus.com/inward/record.url?scp=44449104165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449104165&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2008.04.051

DO - 10.1016/j.bmc.2008.04.051

M3 - Article

VL - 16

SP - 6027

EP - 6033

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 11

ER -